[PDF] Top 20 <p>Risk Assessment for Breast Cancer Development and Its Clinical Impact on Screening Performance in Iranian Women</p>
Has 10000 "<p>Risk Assessment for Breast Cancer Development and Its Clinical Impact on Screening Performance in Iranian Women</p>" found on our website. Below are the top 20 most common "<p>Risk Assessment for Breast Cancer Development and Its Clinical Impact on Screening Performance in Iranian Women</p>".
<p>Risk Assessment for Breast Cancer Development and Its Clinical Impact on Screening Performance in Iranian Women</p>
... lifetime risk of developing breast ...5-year risk and lifetime risk with demographic and clinical ...mated risk and perceived risk in different dimensions of HBM were ... See full document
10
<p>Modeling risk assessment for breast cancer in symptomatic women: a Saudi Arabian study</p>
... malignant breast biopsies and 229 (36.2%) benign breast biop- sies were ...analyzed. Women ≥40 years old (aOR: ...1.861–5.024, P=0.001), and with a family history of breast ... See full document
8
Disparities in breast screening, stage at diagnosis, cancer treatment and the subsequent risk of cancer death: a retrospective, matched cohort of aboriginal and non aboriginal women with breast cancer
... of cancer care from detec- tion to treatment, the data do not inform on re-screening or post-screening assessment [16], time to treatment, whether treatment courses were completed, or the ... See full document
11
Failure to Engage in Breast Screening and Risk Assessment Results in More Advanced Stage at Diagnosis
... for women in their 40s and 32% for women in their ...without screening and feel that this represents over diagnosis ...National performance indicator [37] is that surgery occurs in over 90% of ... See full document
10
Women’s Performance of Breast Cancer Screening (Breast Self Examination, Clinical Breast Exam and Mammography)
... Globally, breast cancer is the second leading cause of death in women and ranked number one among cancerous diseases in women who live in Saudi Ara- bia [3] [4] ...of women toward ... See full document
12
Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland
... 121 women diagnosed with breast or ovarian cancer from families fulfilling one of the following cri- teria: 1) three or more breast and/or ovarian cancer cases in first or second-degree ... See full document
10
Cost effectiveness of MRI compared to mammography for breast cancer screening in a high risk population
... having breast cancer, living, dying, having been diagnosed with node positive breast cancer, having experienced a false positive examination, having to experience screening, and having ... See full document
8
<p>Epidemiological characteristics of and risk factors for breast cancer in the world</p>
... terms: breast cancer, risk factors, incidence, and mortality and a com- bination of these ...of breast cancer including epidemiology and risk factors were included in the ... See full document
14
ACCUMULATIVE EFFECT OF RISK FACTORS FOR GETTING BREAST CANCER IN IRAQI WOMEN
... 50 women with normal breast (NB), and 131 breast diseased [111 from them are with malignant breast cancer (MB) and 20 with benign-breast disease (BB)], the diagnosis was ... See full document
10
<p>Caveolin-1: a multifaceted driver of breast cancer progression and its application in clinical treatment</p>
... and breast cancer are ...the breast cancer cell membrane, and Cav1 promotes breast cancer cell proliferation via EGFR or HER2-induced mitogenic signaling ...to cancer ... See full document
14
<p>RAP80 expression in breast cancer and its relationship with apoptosis in breast cancer cells</p>
... Breast cancer cell lines including MCF-7 (chemotherapy responsive, ER + , PR + / - , Her-2 - , Ki67 low), ZR-75 (usually endocrine responsive, variable response to chemotherapy, ER + , PR + / - , HER2 + , ... See full document
10
An Enhanced Risk Assessment Framework for Software Development in Multiple Projects Environment
... a risk assessment method and a prototype tool originally based on data that gather further data as the ...a risk prioritization and risk matrix, and a fuzzy method-based tool to facilitate the ... See full document
5
Mammography screening in Nigeria – a critical comparison to other countries
... mammography screening program) when compared to the screening program organised in other countries (Australia, Canada, UK, and USA) appear to be lagging behind the four comparative developed countries in ... See full document
22
<p>The role of digital breast tomosynthesis in breast cancer screening: a manufacturer- and metrics-specific analysis</p>
... the assessment of the different implementations with which DBT can be introduced in ...realistic breast cancer images under speci fi c implementations, and their observa- tion by real observers ... See full document
20
APOBEC3 Deletion is Associated with Breast Cancer Risk in a Sample of Southeast Iranian Population
... for breast cancer in Chinese women, which was located between the fifth exon of APOBEC3A and the eighth exon of APOBEC3B ...among women of European ancestry ...and risk of various ... See full document
6
<p>The Clinical Significance of <em>PPEF1</em> as a Promising Biomarker and Its Potential Mechanism in Breast Cancer</p>
... Kaplan-Meier Plotter tool was used to analyze the correla- tion between the PPEF1 expression and BC survival. High expression of PPEF1 was a poor prognostic marker for 10- year overall survival (OS) in TCGA cohort (HR = ... See full document
16
<p>Apolipoprotein A1 and B as risk factors for development of intraocular metastasis in patients with breast cancer</p>
... predict cancer development and ...gastric cancer (GC), where those with high ApoB/ApoA1 ratios had shorter survival ...a risk factor for IOM in patients with breast cancer. ... See full document
8
COMPARISON OF BENIGN AND MALIGNANT BREAST DISEASE-RISK FACTORS AND FREQUENCIES IN SAMPLES REFERRED TO PATHOLOGY LABORATORY OF AHWAZ UNIVERSITY OF MEDICAL SCIENCES FROM 2006 TO 2017 (FUNDED WORK)
... In the present study, mean ages of case and control group at the time of diagnosis were 52.11 and 35.31 respectively, which indicate that mean age in case group was higher than the control group (p=0.033). The ... See full document
7
What Are the Recommended Timing and Screening Modalities for Women at Higher Risk of Developing Breast Cancer? A Clin-IQ
... lifetime risk of >25% were offered 18 monthly screenings in addition to their three yearly screenings from age 51 to 60, which is normally covered by the National Health Service Breast Screening ... See full document
6
SURVEY ON THE AWARENESS OF RISK FACTORS ASSOCIATED WITH BREAST CANCER AMONG WOMEN ATTENDING ANTE-NATAL CLINIC AT IMO STATE UNIVERSITY TEACHING HOSPITAL (IMSUTH), ORLU
... of risk factors associated with breast cancer, its protective and screening measures among pregnant women attending ante-natal clinic at Imo State University Teaching Hospital ... See full document
6
Related subjects